Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Proteoglycans | 2 | 2020 | 130 | 1.35 | Why? |
| Neoplasm Proteins | 2 | 2020 | 501 | 0.97 | Why? |
| Insulin-Like Growth Factor Binding Proteins | 2 | 2018 | 35 | 0.85 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 2 | 2018 | 45 | 0.85 | Why? |
| Collagen Type VI | 1 | 2019 | 4 | 0.81 | Why? |
| Insulin Resistance | 3 | 2019 | 669 | 0.74 | Why? |
| Cardio-Renal Syndrome | 1 | 2018 | 68 | 0.66 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2019 | 245 | 0.66 | Why? |
| Cisplatin | 1 | 2017 | 209 | 0.60 | Why? |
| Troponin T | 1 | 2021 | 771 | 0.58 | Why? |
| Myalgia | 1 | 2020 | 1015 | 0.55 | Why? |
| Natriuretic Peptide, Brain | 2 | 2021 | 1215 | 0.55 | Why? |
| Fatty Liver | 1 | 2018 | 299 | 0.54 | Why? |
| Alanine Transaminase | 1 | 2020 | 1329 | 0.53 | Why? |
| Heart Injuries | 1 | 2021 | 608 | 0.53 | Why? |
| Lectins | 1 | 2017 | 311 | 0.52 | Why? |
| Blood Glucose | 3 | 2018 | 3642 | 0.52 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.51 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 5277 | 0.51 | Why? |
| Hypoglycemic Agents | 2 | 2017 | 2165 | 0.50 | Why? |
| Cardiovascular System | 1 | 2020 | 750 | 0.48 | Why? |
| Turkey | 5 | 2020 | 3937 | 0.48 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 907 | 0.39 | Why? |
| Angiotensin Receptor Antagonists | 3 | 2020 | 3892 | 0.38 | Why? |
| Antihypertensive Agents | 2 | 2020 | 1962 | 0.38 | Why? |
| Stroke Volume | 1 | 2019 | 2153 | 0.37 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.37 | Why? |
| Peptide Fragments | 1 | 2019 | 2075 | 0.36 | Why? |
| Risk Reduction Behavior | 1 | 2015 | 946 | 0.34 | Why? |
| Heart Failure | 2 | 2019 | 6638 | 0.33 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.32 | Why? |
| Cough | 1 | 2020 | 4891 | 0.31 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2017 | 6166 | 0.28 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.28 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.28 | Why? |
| Case-Control Studies | 7 | 2021 | 17671 | 0.27 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Heart Ventricles | 2 | 2021 | 1139 | 0.23 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.21 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.21 | Why? |
| Mannose-Binding Lectin | 1 | 2021 | 131 | 0.21 | Why? |
| Area Under Curve | 2 | 2018 | 2564 | 0.20 | Why? |
| Retrospective Studies | 9 | 2021 | 105322 | 0.20 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.20 | Why? |
| Aged | 14 | 2021 | 215776 | 0.20 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.20 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.19 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.18 | Why? |
| APACHE | 1 | 2021 | 682 | 0.18 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2018 | 86 | 0.17 | Why? |
| Male | 17 | 2021 | 367725 | 0.17 | Why? |
| Female | 17 | 2021 | 380317 | 0.16 | Why? |
| Hospitalization | 4 | 2020 | 54280 | 0.16 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.16 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.16 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.16 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.16 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.15 | Why? |
| Diuretics | 1 | 2018 | 326 | 0.15 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.15 | Why? |
| GPI-Linked Proteins | 1 | 2017 | 317 | 0.15 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.15 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.15 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.15 | Why? |
| ROC Curve | 2 | 2018 | 6024 | 0.14 | Why? |
| Mutation, Missense | 1 | 2021 | 863 | 0.14 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.14 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.14 | Why? |
| Albuminuria | 1 | 2015 | 164 | 0.13 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.13 | Why? |
| Adult | 11 | 2021 | 244371 | 0.13 | Why? |
| Ventricular Dysfunction, Right | 1 | 2021 | 639 | 0.13 | Why? |
| Fasting | 1 | 2018 | 555 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2021 | 993 | 0.12 | Why? |
| Humans | 19 | 2021 | 930598 | 0.11 | Why? |
| Diabetic Nephropathies | 1 | 2015 | 315 | 0.11 | Why? |
| Heart | 1 | 2021 | 1791 | 0.11 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.11 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.10 | Why? |
| Metformin | 1 | 2017 | 640 | 0.10 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Down-Regulation | 1 | 2015 | 1416 | 0.09 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.09 | Why? |
| Linear Models | 1 | 2015 | 1914 | 0.09 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.09 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.09 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.08 | Why? |
| Glycated Hemoglobin A | 1 | 2015 | 1316 | 0.08 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.08 | Why? |
| Combined Modality Therapy | 1 | 2015 | 3395 | 0.08 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.07 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.07 | Why? |
| Multivariate Analysis | 1 | 2015 | 5440 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.06 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.06 | Why? |
| Renin-Angiotensin System | 1 | 2019 | 3661 | 0.06 | Why? |
| Odds Ratio | 1 | 2015 | 5861 | 0.06 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.06 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Diet | 1 | 2015 | 2052 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Travel | 1 | 2020 | 7220 | 0.06 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.05 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Echocardiography | 2 | 2021 | 3661 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
| Exercise | 1 | 2015 | 6771 | 0.04 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Protein Interaction Maps | 1 | 2021 | 1333 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Time Factors | 1 | 2015 | 31397 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.02 | Why? |
| Treatment Outcome | 1 | 2015 | 51732 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2021 | 4027 | 0.02 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |